Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol (Q34447485)

2 August 2017

Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol (English)

1 reference

2 August 2017

0 references

4

Beilin LJ

1 reference

2 August 2017

Vandongen R

1

1 reference

2 August 2017

Margetts B

series ordinal

2

1 reference

2 August 2017

Deklerk N

series ordinal

3

1 reference

2 August 2017

Rogers P

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

21

1 reference

2 August 2017

6

1 reference

2 August 2017

627-632

1 reference

Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

Relationship of plasma catecholamines to blood pressure in hypertensive patients during beta-adrenoceptor blockade with and without intrinsic sympathomimetic activity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

Blood pressure and norepinephrine spillover during propranolol infusion in humans.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

Studies on the effects of propranolol on plasma catecholamine levels in patients with essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400981

Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension

6 July 2018

1 reference

12 December 2020

Improvement in depressed cardiac function in hypertensive patients during pindolol treatment

1 reference

12 December 2020

Differential Effects of Long-Term Cardioselective and Nonselective Beta-Receptor Blockade on Plasma Catecholamines During and After Physical Exercise in Hypertensive Patients

1 reference

12 December 2020

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

12 December 2020

Free and sulfate-conjugated catecholamines during exercise in man

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB05226.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference